Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$77,716
-1.46%
Shares
Shares Volume: 2,825 Shares
Average Share Price: $27.51
INSIDER
Heyman Richard A.
(Director)
reported on Oct 8 2024
traded on Oct 4 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 191,085 |
| PURCHASES/SALES 1Y | 0 / 18 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $32,103.53 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 86 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $921,640.31 |
| COMPANY PREVIOUS TRADES |